QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 correction-siga-technologies-q2-eps-049-up-from-003-yoy-sales-81120m-up-from-21811m-yoy

SIGA Technologies (NASDAQ:SIGA) reported quarterly earnings of $0.49 per share. This is a 1533.33 percent increase over earning...

 siga-technologies-q1-eps-001-down-from-014-yoy-sales-704m-down-from-2543m-yoy

SIGA Technologies (NASDAQ:SIGA) reported quarterly losses of $(0.01) per share. This is a 107.14 percent decrease over earnings...

 watching-siga-technologies-shares-see-volume-to-the-upside-earlier-reports-say-nc-department-of-health-and-human-services-said-mpox-found-in-wastewater-in-north-carolina-from-samples-collected-on-march-25-march-28--april-8-from-treatment-plant-in-greenville-no-mpox-clade-i-cases-have-been-reported-to-date

https://www.ncdhhs.gov/news/press-releases/2025/04/22/mpox-found-wastewater-north-carolina-ncdhhs-urges-public-and-providers-be...

 nih-trial-finds-tecovirimat-ineffective-as-monotherapy-for-mpox

A NIH-led trial found tecovirimat ineffective in reducing mpox lesion healing time or pain relief. The study was halted in 2024...

 tecovirimat-is-safe-but-ineffective-as-treatment-for-clade-ii-mpox---nih

https://www.niaid.nih.gov/news-events/tecovirimat-safe-ineffective-treatment-clade-ii-mpoxThe antiviral drug tecovirimat used w...

 siga-technologies-q4-2024-gaap-eps-063-down-from-101-yoy-sales-8140m-down-from-11650m-yoy

SIGA Technologies (NASDAQ:SIGA) reported quarterly earnings of $0.63 per share. This is a 37.62 percent decrease over earnings ...

 japan-approves-siga-technologies-antiviral-as-first-for-smallpox-mpox

Japan approves SIGA's TEPOXX for smallpox, mpox, and cowpox, expanding antiviral availability for orthopoxviruses with prov...

 siga-technologies-says-tepoxx-tecovirimat-200-mg-capsules-has-received-regulatory-approval-in-japan

Regulatory decision marks first approval in Japan of an antiviral for the treatment of orthopoxviruses including smallpox, mpox...

 why-rumble-shares-are-trading-higher-by-around-43-here-are-20-stocks-moving-premarket

Shares of Rumble Inc.

 nih-study-finds-tecovirimat-was-safe-but-did-not-improve-mpox-resolution-or-pain

https://www.niaid.nih.gov/news-events/nih-study-finds-tecovirimat-was-safe-did-not-improve-mpox-resolution-or-painStudy Examine...

 siga-technologies-q3-eps-002-up-from-001-yoy-sales-1000m-up-from-923m-yoy

SIGA Technologies (NASDAQ:SIGA) reported quarterly earnings of $0.02 per share. This is a 300 percent increase over losses of $...

 siga-technologies-enters-agreement-to-supply-tpoxx-tecovirimat-in-morocco

The contract was executed in response to a request from the Ministry of Health in Morocco to make the therapy available in the ...

 who-seeks-135m-in-funding-to-fight-mpox-outbreak-can-be-controlled-and-can-be-stopped

To fight the mpox outbreak in Africa, the World Health Organization calls for funding help for its six-month plan.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION